Status
Conditions
Treatments
About
Extracellular vesicles, due to their ease of extraction and ability to represent the cells from which they originate, have high potential in the field of personalized medicine, especially in the identification of new early bio-markers of cancer, including hepatocellular carcinoma. Nevertheless, the development of high-throughput diagnostic methods in this area is still in its infancy, and the design of new integrated technological solutions is of great interest and topicality. The main hypothesis of this study is that the development of a novel technology integrating resonant gold nanostructures in the mid-infrared can significantly contribute to the development of new approaches for the diagnosis of hepatocellular carcinoma.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion
Exclusion
64 participants in 2 patient groups
Loading...
Central trial contact
Gabriele Ciasca, Professor; FABRIZIO PIZZOLANTE, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal